Storia della carriera di Jack Tsai
Precedenti posizioni note di Jack Tsai
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INHIBRX, INC. | Corporate Officer/Principal | 28/10/2021 | 01/09/2022 |
Formazione di Jack Tsai
| MIT Sloan School of Management | Masters Business Admin |
| Rochester Christian University | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Borsa valori
- Insiders
- Jack Tsai
- Esperienza
